Akouos
access to multiple cell types opens large target landscape | Akouos
Company
Deck Type
IPO
Deck date
June 2020
Slide
22 of 48
Related slides by other companies
LumiraDx
Investor Presentation
March 2023
our platform allows for multiple sample types and test technologies on common strip architecture | LumiraDx
Mink Therapeutics
Investor Day
November 2022
clinical challenges multiple myeloma is still incurable car cells do more than just kill the tumor cells mink | Mink Therapeutics
AbCellera
Investor Conference
April 2023
portfolio diversified across modalities partner size and deal type as ale | AbCellera
LumiraDx
Investor Presentation
September 2022
our platform allows for multiple sample types and test technologies on common strip architecture | LumiraDx
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights